Efficacy and safety of zanubrutinib monotherapy for chronic lymphocytic leukemia/small lymphocytic lymphoma: A multicenter, real-world study in China

被引：0
|
作者：
Luo, Jing [1 ]
Zhang, Jiaojiao [1 ]
Liu, Ligen [2 ]
Wei, Rong [3 ]
Yao, Yonghua [4 ]
Xu, Min [5 ]
Shi, Jumei [6 ]
Yang, Jianmin [7 ]
Hou, Jian [8 ]
Wang, Jin [1 ]
Mi, Jian-Qing [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Hematol, Natl Res Ctr Translat Med Shanghai,Sch Med,State K, Shanghai 200025, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Tongren Hosp, Dept Hematol, Shanghai, Peoples R China
[3] Tongji Univ, Shanghai Peoples Hosp 10, Peoples Hosp 10, Dept Hematol, Shanghai, Peoples R China
[4] Univ Shanghai Sci & Technol, Shidong Hosp, Dept Hematol, Shanghai, Peoples R China
[5] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Hematol, Shanghai, Peoples R China
[6] Tongji Univ, Shanghai East Hosp, Shanghai Peoples Hosp 10, Peoples Hosp 10, Shanghai, Peoples R China
[7] Second Mil Med Univ, Changhai Hosp, Dept Hematol, Shanghai, Peoples R China
[8] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Hematol, Shanghai, Peoples R China
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2025年 / 100卷 / 01期
关键词：
D O I：
10.1002/ajh.27519
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：172 / 175
页数：4
相关论文
共 50 条
  • [21] Real-world patterns and sequences of targeted therapy use in chronic lymphocytic leukemia and small lymphocytic lymphoma in the United States: a longitudinal study
    Huntington, Scott F.
    Cheng, Wendy Y.
    Sarpong, Eric M.
    Leng, Siyang
    Farooqui, Mohammed Z. H.
    Agu, Uchechukwu Samuel
    Catillon, Maryaline
    Lejeune, Dominique
    Downes, Nathaniel
    Matay, Lisa
    Duh, Mei Sheng
    De Nigris, Enrico
    LEUKEMIA & LYMPHOMA, 2024, 65 (07) : 932 - 942
  • [22] Real-world patterns and sequences of targeted therapy use in chronic lymphocytic leukemia and small lymphocytic lymphoma in the United States: a longitudinal study
    Huntington, Scott F.
    Cheng, Wendy Y.
    Sarpong, Eric M.
    Leng, Siyang
    Farooqui, Mohammed Z. H.
    Agu, Uchechukwu Samuel
    Catillon, Maryaline
    Lejeune, Dominique
    Downes, Nathaniel
    Matay, Lisa
    Duh, Mei Sheng
    De Nigris, Enrico
    LEUKEMIA & LYMPHOMA, 2024, : 932 - 942
  • [23] Treatment Patterns of Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in the Era of Targeted Therapy: A Real-World United States Study
    Yang, Xiaoqin
    Zanardo, Enrico
    Lejeune, Dominique
    De Nigris, Enrico
    Sarpong, Eric
    Farooqui, Mohammed Z. H.
    Donzella, Sidney M.
    Laliberte, Francois
    BLOOD, 2022, 140 : 10932 - 10933
  • [24] New drug approval: Zanubrutinib in monotherapy for chronic lymphocytic leukemia
    Cavalieri, Doriane
    Thiam, Marietou
    BULLETIN DU CANCER, 2023, 110 (7-8) : 744 - 745
  • [25] Real-World Patient Characteristics, Treatment Patterns, and Outcomes in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia in China: A Retrospective Analysis Using a Real-World Database
    Liu, Yin
    Chen, Yanfei
    Xiao, Yue
    Huang, Ruijian
    Jiang, Feng
    Yi, Shuhua
    Zhou, Jifang
    BLOOD, 2023, 142
  • [26] Zanubrutinib more effective and better tolerated than ibrutinib for chronic lymphocytic leukemia and small lymphocytic lymphoma
    Nierengarten, Mary Beth
    CANCER, 2023, 129 (10) : 1466 - 1466
  • [27] Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study
    Wei Xu
    Shenmiao Yang
    Keshu Zhou
    Ling Pan
    Zengjun Li
    Jianfeng Zhou
    Sujun Gao
    Daobin Zhou
    Jianda Hu
    Ru Feng
    Haiwen Huang
    Meng Ji
    Haiyi Guo
    Jane Huang
    William Novotny
    Shibao Feng
    Jianyong Li
    Journal of Hematology & Oncology, 13
  • [28] Real-world time to discontinuation of first-line venetoclax plus obinutuzumab in chronic lymphocytic leukemia/small lymphocytic lymphoma
    Lu, Xiaoxiao
    Emond, Bruno
    Qureshi, Zaina P.
    Wu, Linda H.
    Forbes, Shaun P.
    Hilts, Annalise
    Liu, Stephanie
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    Huang, Qing
    Rogers, Kerry A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, : 1227 - 1235
  • [29] Real-world outcomes of venetoclax and rituximab for chronic lymphocytic leukemia/small lymphocytic lymphoma: A retrospective analysis of nine Japanese cases
    Saburi, Masuho
    Nishikawa, Takumi
    Miyazaki, Yasuhiko
    Kohno, Kazuhiro
    Sakata, Masanori
    Okuhiro, Kazuki
    Nakayama, Toshiyuki
    Ohtsuka, Eiichi
    Ogata, Masao
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2024, 64 (02) : 152 - 155
  • [30] Real-world time to discontinuation of first-line venetoclax plus binutuzumab in chronic lymphocytic leukemia/small lymphocytic lymphoma
    Lu, Xiaoxiao
    Emond, Bruno
    Qureshi, Zaina P.
    Wu, Linda H.
    Forbes, Shaun P.
    Hilts, Annalise
    Liu, Stephanie
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    Huang, Qing
    Rogers, Kerry A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2023,
12345